Taysha Gene Therapies (TSHA) Preferred Shares Issued (2020)
Taysha Gene Therapies' (TSHA) quarterly Preferred Shares Issued came in at -$174000.0 in Q4 2020, down 101.59% quarter-over-quarter from $11.0 million in Q3 2020.
Taysha Gene Therapies (TSHA) Preferred Shares Issued (2020) Analysis & Trends
Taysha Gene Therapies has disclosed Preferred Shares Issued across 1 years of filings, most recently posting -$174000.0 for Q4 2020.
- Preferred Shares Issued for Q4 2020 came in at -$174000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $29.4 million (changed N/A YoY), and the FY2020 annual result was $29.4 million, changed N/A from the prior year.
- Preferred Shares Issued came in at -$174000.0 for Q4 2020 at Taysha Gene Therapies, down from $11.0 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $18.0 million in Q1 2020 to a low of -$174000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Taysha Gene Therapies | 2.36 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -174,000.00 |
| Dec 31, 2020 | -174,000.00 |
| Sep 30, 2020 | 10.97 Mn |
| Sep 30, 2020 | 10.97 Mn |
| Jun 30, 2020 | 600,000.00 |
| Jun 30, 2020 | 600,000.00 |
| Mar 31, 2020 | 18.00 Mn |
| Mar 31, 2020 | 18.00 Mn |